News | November 15, 2023
JB Pharma Q2 FY24 PAT up 36% to Rs. 151 Cr
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
The company has raised US$4.5 million in funding for its AI operating system
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Lack of technology transfer stands out as a formidable barrier
In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Investment is additive to KKR’s existing health care growth strategy
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Subscribe To Our Newsletter & Stay Updated
